Global Folliculotropic Mycosis Fungoides Treatment Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Folliculotropic Mycosis Fungoides Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Folliculotropic Mycosis Fungoides Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Specialty Clinic are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Folliculotropic Mycosis Fungoides Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. 

Globally, Folliculotropic Mycosis Fungoides Treatment key companies include Takeda Pharmaceutical Company, Merck, Seattle Genetics, Kyowa Kirin, Eisai, Helsinn Healthcare, Horizon Therapeutics, Celegene Corporation and Azurity Pharmaceuticals, etc. Takeda Pharmaceutical Company, Merck, Seattle Genetics are top 3 players and held % share in total in 2022.

Folliculotropic Mycosis Fungoides Treatment can be divided into Small Molecule and Biologics, etc. Small Molecule is the mainstream product in the market, accounting for % share globally in 2022.

Folliculotropic Mycosis Fungoides Treatment is widely used in various fields, such as Hospital, Specialty Clinic and Others,, etc. Hospital provides greatest supports to the Folliculotropic Mycosis Fungoides Treatment industry development. In 2022, global % share of Folliculotropic Mycosis Fungoides Treatment went into Hospital filed. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Folliculotropic Mycosis Fungoides Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Takeda Pharmaceutical Company
    Merck
    Seattle Genetics
    Kyowa Kirin
    Eisai
    Helsinn Healthcare
    Horizon Therapeutics
    Celegene Corporation
    Azurity Pharmaceuticals
    Elorac
    Soligenix
    Actelion Pharmaceuticals

Segment by Type
    Small Molecule
    Biologics

Segment by Application
    Hospital
    Specialty Clinic
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Folliculotropic Mycosis Fungoides Treatment market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Folliculotropic Mycosis Fungoides Treatment introduction, etc. Folliculotropic Mycosis Fungoides Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Folliculotropic Mycosis Fungoides Treatment market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.

 1 Market Overview of Folliculotropic Mycosis Fungoides Treatment
    1.1 Folliculotropic Mycosis Fungoides Treatment Market Overview
        1.1.1 Folliculotropic Mycosis Fungoides Treatment Product Scope
        1.1.2 Folliculotropic Mycosis Fungoides Treatment Market Status and Outlook
    1.2 Global Folliculotropic Mycosis Fungoides Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
    1.3 Global Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2018-2029)
    1.4 Global Folliculotropic Mycosis Fungoides Treatment Historic Market Size by Region (2018-2023)
    1.5 Global Folliculotropic Mycosis Fungoides Treatment Market Size Forecast by Region (2024-2029)
    1.6 Key Regions, Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029)
        1.6.1 North America Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029)
        1.6.2 Europe Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029)
        1.6.3 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029)
        1.6.4 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029)
        1.6.5 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029)

 2 Folliculotropic Mycosis Fungoides Treatment Market by Type
    2.1 Introduction
        2.1.1 Small Molecule
        2.1.2 Biologics
    2.2 Global Folliculotropic Mycosis Fungoides Treatment Market Size by Type: 2018 VS 2022 VS 2029
        2.2.1 Global Folliculotropic Mycosis Fungoides Treatment Historic Market Size by Type (2018-2023)
        2.2.2 Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Type (2024-2029)
    2.3 Key Regions Market Size by Type
        2.3.1 North America Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Type (2018-2029)
        2.3.2 Europe Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Type (2018-2029)
        2.3.3 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Type (2018-2029)
        2.3.4 Latin America Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Type (2018-2029)
        2.3.5 Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Type (2018-2029)

 3 Folliculotropic Mycosis Fungoides Treatment Market Overview by Application
    3.1 Introduction
        3.1.1 Hospital
        3.1.2 Specialty Clinic
        3.1.3 Others
    3.2 Global Folliculotropic Mycosis Fungoides Treatment Market Size by Application: 2018 VS 2022 VS 2029
        3.2.1 Global Folliculotropic Mycosis Fungoides Treatment Historic Market Size by Application (2018-2023)
        3.2.2 Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Application (2024-2029)
    3.3 Key Regions Market Size by Application
        3.3.1 North America Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Application (2018-2029)
        3.3.2 Europe Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Application (2018-2029)
        3.3.3 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Application (2018-2029)
        3.3.4 Latin America Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Application (2018-2029)
        3.3.5 Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue Breakdown by Application (2018-2029)

 4 Folliculotropic Mycosis Fungoides Treatment Competition Analysis by Players
    4.1 Global Folliculotropic Mycosis Fungoides Treatment Market Size by Players (2018-2023)
    4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Folliculotropic Mycosis Fungoides Treatment as of 2022)
    4.3 Date of Key Players Enter into Folliculotropic Mycosis Fungoides Treatment Market
    4.4 Global Top Players Folliculotropic Mycosis Fungoides Treatment Headquarters and Area Served
    4.5 Key Players Folliculotropic Mycosis Fungoides Treatment Product Solution and Service
    4.6 Competitive Status
        4.6.1 Folliculotropic Mycosis Fungoides Treatment Market Concentration Rate
        4.6.2 Mergers & Acquisitions, Expansion Plans

 5 Company (Top Players) Profiles
    5.1 Takeda Pharmaceutical Company
        5.1.1 Takeda Pharmaceutical Company Profile
        5.1.2 Takeda Pharmaceutical Company Main Business
        5.1.3 Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.1.4 Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.1.5 Takeda Pharmaceutical Company Recent Developments
    5.2 Merck
        5.2.1 Merck Profile
        5.2.2 Merck Main Business
        5.2.3 Merck Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.2.4 Merck Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.2.5 Merck Recent Developments
    5.3 Seattle Genetics
        5.3.1 Seattle Genetics Profile
        5.3.2 Seattle Genetics Main Business
        5.3.3 Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.3.4 Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.3.5 Kyowa Kirin Recent Developments
    5.4 Kyowa Kirin
        5.4.1 Kyowa Kirin Profile
        5.4.2 Kyowa Kirin Main Business
        5.4.3 Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.4.4 Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.4.5 Kyowa Kirin Recent Developments
    5.5 Eisai
        5.5.1 Eisai Profile
        5.5.2 Eisai Main Business
        5.5.3 Eisai Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.5.4 Eisai Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.5.5 Eisai Recent Developments
    5.6 Helsinn Healthcare
        5.6.1 Helsinn Healthcare Profile
        5.6.2 Helsinn Healthcare Main Business
        5.6.3 Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.6.4 Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.6.5 Helsinn Healthcare Recent Developments
    5.7 Horizon Therapeutics
        5.7.1 Horizon Therapeutics Profile
        5.7.2 Horizon Therapeutics Main Business
        5.7.3 Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.7.4 Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.7.5 Horizon Therapeutics Recent Developments
    5.8 Celegene Corporation
        5.8.1 Celegene Corporation Profile
        5.8.2 Celegene Corporation Main Business
        5.8.3 Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.8.4 Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.8.5 Celegene Corporation Recent Developments
    5.9 Azurity Pharmaceuticals
        5.9.1 Azurity Pharmaceuticals Profile
        5.9.2 Azurity Pharmaceuticals Main Business
        5.9.3 Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.9.4 Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.9.5 Azurity Pharmaceuticals Recent Developments
    5.10 Elorac
        5.10.1 Elorac Profile
        5.10.2 Elorac Main Business
        5.10.3 Elorac Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.10.4 Elorac Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.10.5 Elorac Recent Developments
    5.11 Soligenix
        5.11.1 Soligenix Profile
        5.11.2 Soligenix Main Business
        5.11.3 Soligenix Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.11.4 Soligenix Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.11.5 Soligenix Recent Developments
    5.12 Actelion Pharmaceuticals
        5.12.1 Actelion Pharmaceuticals Profile
        5.12.2 Actelion Pharmaceuticals Main Business
        5.12.3 Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
        5.12.4 Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) & (2018-2023)
        5.12.5 Actelion Pharmaceuticals Recent Developments

 6 North America
    6.1 North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2018-2029)
    6.2 United States
    6.3 Canada

 7 Europe
    7.1 Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2018-2029)
    7.2 Germany
    7.3 France
    7.4 U.K.
    7.5 Italy
    7.6 Russia
    7.7 Nordic Countries
    7.8 Rest of Europe

 8 Asia-Pacific
    8.1 Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2018-2029)
    8.2 China
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australia
    8.8 Rest of Asia-Pacific

 9 Latin America
    9.1 Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2018-2029)
    9.2 Mexico
    9.3 Brazil
    9.4 Rest of Latin America

 10 Middle East & Africa
    10.1 Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2018-2029)
    10.2 Turkey
    10.3 Saudi Arabia
    10.4 UAE
    10.5 Rest of Middle East & Africa

 11 Folliculotropic Mycosis Fungoides Treatment Market Dynamics
    11.1 Folliculotropic Mycosis Fungoides Treatment Industry Trends
    11.2 Folliculotropic Mycosis Fungoides Treatment Market Drivers
    11.3 Folliculotropic Mycosis Fungoides Treatment Market Challenges
    11.4 Folliculotropic Mycosis Fungoides Treatment Market Restraints

 12 Research Finding /Conclusion

 13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List

List of Tables
    Table 1. Global Market Folliculotropic Mycosis Fungoides Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Folliculotropic Mycosis Fungoides Treatment Market Size Share by Region (2018-2023)
    Table 4. Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Folliculotropic Mycosis Fungoides Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Folliculotropic Mycosis Fungoides Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2018-2023)
    Table 9. Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2024-2029)
    Table 11. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Folliculotropic Mycosis Fungoides Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Folliculotropic Mycosis Fungoides Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2018-2023)
    Table 24. Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2024-2029)
    Table 26. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Folliculotropic Mycosis Fungoides Treatment Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Folliculotropic Mycosis Fungoides Treatment as of 2022)
    Table 39. Date of Key Players Enter into Folliculotropic Mycosis Fungoides Treatment Market
    Table 40. Global Folliculotropic Mycosis Fungoides Treatment Key Players Headquarters and Area Served
    Table 41. Folliculotropic Mycosis Fungoides Treatment Product Solution and Service
    Table 42. Global Folliculotropic Mycosis Fungoides Treatment Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Takeda Pharmaceutical Company Basic Information List
    Table 45. Takeda Pharmaceutical Company Description and Business Overview
    Table 46. Takeda Pharmaceutical Company Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Takeda Pharmaceutical Company (2018-2023)
    Table 48. Takeda Pharmaceutical Company Recent Developments
    Table 49. Merck Basic Information List
    Table 50. Merck Description and Business Overview
    Table 51. Merck Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Merck (2018-2023)
    Table 53. Merck Recent Developments
    Table 54. Seattle Genetics Basic Information List
    Table 55. Seattle Genetics Description and Business Overview
    Table 56. Seattle Genetics Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Seattle Genetics (2018-2023)
    Table 58. Seattle Genetics Recent Developments
    Table 59. Kyowa Kirin Basic Information List
    Table 60. Kyowa Kirin Description and Business Overview
    Table 61. Kyowa Kirin Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Kyowa Kirin (2018-2023)
    Table 63. Kyowa Kirin Recent Developments
    Table 64. Eisai Basic Information List
    Table 65. Eisai Description and Business Overview
    Table 66. Eisai Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Eisai (2018-2023)
    Table 68. Eisai Recent Developments
    Table 69. Helsinn Healthcare Basic Information List
    Table 70. Helsinn Healthcare Description and Business Overview
    Table 71. Helsinn Healthcare Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Helsinn Healthcare (2018-2023)
    Table 73. Helsinn Healthcare Recent Developments
    Table 74. Horizon Therapeutics Basic Information List
    Table 75. Horizon Therapeutics Description and Business Overview
    Table 76. Horizon Therapeutics Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Horizon Therapeutics (2018-2023)
    Table 78. Horizon Therapeutics Recent Developments
    Table 79. Celegene Corporation Basic Information List
    Table 80. Celegene Corporation Description and Business Overview
    Table 81. Celegene Corporation Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Celegene Corporation (2018-2023)
    Table 83. Celegene Corporation Recent Developments
    Table 84. Azurity Pharmaceuticals Basic Information List
    Table 85. Azurity Pharmaceuticals Description and Business Overview
    Table 86. Azurity Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Azurity Pharmaceuticals (2018-2023)
    Table 88. Azurity Pharmaceuticals Recent Developments
    Table 89. Elorac Basic Information List
    Table 90. Elorac Description and Business Overview
    Table 91. Elorac Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Elorac (2018-2023)
    Table 93. Elorac Recent Developments
    Table 94. Soligenix Basic Information List
    Table 95. Soligenix Description and Business Overview
    Table 96. Soligenix Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Soligenix (2018-2023)
    Table 98. Soligenix Recent Developments
    Table 99. Actelion Pharmaceuticals Basic Information List
    Table 100. Actelion Pharmaceuticals Description and Business Overview
    Table 101. Actelion Pharmaceuticals Folliculotropic Mycosis Fungoides Treatment Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Folliculotropic Mycosis Fungoides Treatment Business of Actelion Pharmaceuticals (2018-2023)
    Table 103. Actelion Pharmaceuticals Recent Developments
    Table 104. North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 105. North America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 106. Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 107. Europe Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 108. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 109. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 110. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 111. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Share by Region (2018-2023)
    Table 112. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Share by Region (2024-2029)
    Table 113. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 114. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 115. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 116. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 117. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 118. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 119. Folliculotropic Mycosis Fungoides Treatment Market Trends
    Table 120. Folliculotropic Mycosis Fungoides Treatment Market Drivers
    Table 121. Folliculotropic Mycosis Fungoides Treatment Market Challenges
    Table 122. Folliculotropic Mycosis Fungoides Treatment Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Folliculotropic Mycosis Fungoides Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Folliculotropic Mycosis Fungoides Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Folliculotropic Mycosis Fungoides Treatment Market Share by Regions: 2022 VS 2029
    Figure 4. Global Folliculotropic Mycosis Fungoides Treatment Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Small Molecule
    Figure 11. Global Small Molecule Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Biologics
    Figure 13. Global Biologics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Global Folliculotropic Mycosis Fungoides Treatment Market Size Share by Type:  2022 & 2029
    Figure 15. North America Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2018-2029)
    Figure 16. Europe Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2018-2029)
    Figure 17. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2018-2029)
    Figure 18. Latin America Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2018-2029)
    Figure 19. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Type (2018-2029)
    Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 21. Specialty Clinic Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 22. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Global Folliculotropic Mycosis Fungoides Treatment Market Size Share by Application: 2022 & 2029
    Figure 24. North America Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2018-2029)
    Figure 25. Europe Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2018-2029)
    Figure 26. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2018-2029)
    Figure 27. Latin America Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2018-2029)
    Figure 28. Middle East and Africa Folliculotropic Mycosis Fungoides Treatment Revenue Market Share by Application (2018-2029)
    Figure 29. Folliculotropic Mycosis Fungoides Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 30. Global Top 5 and Top 10 Players Folliculotropic Mycosis Fungoides Treatment Market Share in 2022
    Figure 31. North America Folliculotropic Mycosis Fungoides Treatment Market Share by Country (2018-2029)
    Figure 32. United States Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 33. Canada Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 34. Germany Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 35. France Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 36. U.K. Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 37. Italy Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 38. Russia Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 39. Nordic Countries Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 40. Asia-Pacific Folliculotropic Mycosis Fungoides Treatment Market Share by Region (2018-2029)
    Figure 41. China Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 42. Japan Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 43. South Korea Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 44. Southeast Asia Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 45. India Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 46. Australia Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 47. Latin America Folliculotropic Mycosis Fungoides Treatment Market Share by Country (2018-2029)
    Figure 48. Mexico Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 49. Brazil Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 50. Middle East & Africa Folliculotropic Mycosis Fungoides Treatment Market Share by Country (2018-2029)
    Figure 51. Turkey Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 52. Saudi Arabia Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 53. UAE Folliculotropic Mycosis Fungoides Treatment Market Size (2018-2029) & (US$ Million)
    Figure 54. Bottom-up and Top-down Approaches for This Report

Folliculotropic Mycosis Fungoides Treatment report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Folliculotropic Mycosis Fungoides Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Hospital and Specialty Clinic are the major drivers for the industry.

North America, Europe and Asia Pacific are the key regions for Folliculotropic Mycosis Fungoides Treatment industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029. 

Globally, Folliculotropic Mycosis Fungoides Treatment key companies include Takeda Pharmaceutical Company, Merck, Seattle Genetics, Kyowa Kirin, Eisai, Helsinn Healthcare, Horizon Therapeutics, Celegene Corporation and Azurity Pharmaceuticals, etc. Takeda Pharmaceutical Company, Merck, Seattle Genetics are top 3 players and held % share in total in 2022.

Folliculotropic Mycosis Fungoides Treatment can be divided into Small Molecule and Biologics, etc. Small Molecule is the mainstream product in the market, accounting for % share globally in 2022.

Folliculotropic Mycosis Fungoides Treatment is widely used in various fields, such as Hospital, Specialty Clinic and Others,, etc. Hospital provides greatest supports to the Folliculotropic Mycosis Fungoides Treatment industry development. In 2022, global % share of Folliculotropic Mycosis Fungoides Treatment went into Hospital filed. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Folliculotropic Mycosis Fungoides Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
    Takeda Pharmaceutical Company
    Merck
    Seattle Genetics
    Kyowa Kirin
    Eisai
    Helsinn Healthcare
    Horizon Therapeutics
    Celegene Corporation
    Azurity Pharmaceuticals
    Elorac
    Soligenix
    Actelion Pharmaceuticals

Segment by Type
    Small Molecule
    Biologics

Segment by Application
    Hospital
    Specialty Clinic
    Others

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        
    Latin America
        Mexico
        Brazil
        
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Each chapter of the report provides detailed information for readers to understand the Folliculotropic Mycosis Fungoides Treatment market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Folliculotropic Mycosis Fungoides Treatment introduction, etc. Folliculotropic Mycosis Fungoides Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Folliculotropic Mycosis Fungoides Treatment market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.